These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28779393)

  • 1. Clinical utility of visualisation of nigrosome-1 in patients with Parkinson's disease.
    Stezin A; Naduthota RM; Botta R; Varadharajan S; Lenka A; Saini J; Yadav R; Pal PK
    Eur Radiol; 2018 Feb; 28(2):718-726. PubMed ID: 28779393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T.
    Schwarz ST; Afzal M; Morgan PS; Bajaj N; Gowland PA; Auer DP
    PLoS One; 2014; 9(4):e93814. PubMed ID: 24710392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).
    Nam Y; Gho SM; Kim DH; Kim EY; Lee J
    J Magn Reson Imaging; 2017 Aug; 46(2):528-536. PubMed ID: 27859983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet).
    Jo M; Oh SH
    Med Phys; 2020 Mar; 47(3):1151-1160. PubMed ID: 31883389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging evaluation of nigrosome 1 and neuromelanin can assist Parkinson's disease diagnosis, but requires an expert neuroradiologist.
    De Pietro Franco Zorzenon C; Almeida Antônio Bienes GH; Duarte Alves E; Tobaru Tibana LA; Carrete Júnior H; Ballalai Ferraz H
    Parkinsonism Relat Disord; 2021 Feb; 83():8-12. PubMed ID: 33418131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal assessment of nigrosomal degeneration in Parkinson's disease.
    Langley J; Huddleston DE; Crosson B; Song DD; Factor SA; Hu X
    Parkinsonism Relat Disord; 2020 Nov; 80():102-107. PubMed ID: 32979784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra high-field SWI of the substantia nigra at 7T: reliability and consistency of the swallow-tail sign.
    Schmidt MA; Engelhorn T; Marxreiter F; Winkler J; Lang S; Kloska S; Goelitz P; Doerfler A
    BMC Neurol; 2017 Oct; 17(1):194. PubMed ID: 29073886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy.
    Simões RM; Castro Caldas A; Grilo J; Correia D; Guerreiro C; Pita Lobo P; Valadas A; Fabbri M; Correia Guedes L; Coelho M; Rosa MM; Ferreira JJ; Reimão S
    BMC Neurol; 2020 Nov; 20(1):432. PubMed ID: 33243166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease.
    Cheng Z; He N; Huang P; Li Y; Tang R; Sethi SK; Ghassaban K; Yerramsetty KK; Palutla VK; Chen S; Yan F; Haacke EM
    Neuroimage Clin; 2020; 25():102103. PubMed ID: 31869769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantia nigra nigrosome-1 imaging correlates with the severity of motor symptoms in Parkinson's disease.
    Chu YT; Yu CF; Fan SP; Chen TF; Chiu MJ; Jang JR; Chiu SI; Lin CH
    J Neurol Sci; 2023 Aug; 451():120731. PubMed ID: 37454574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple quantitative planimetric measurement of nigrosome-1 for clinical settings.
    Chau MT; Agzarian M; Wilcox RA; Dwyer A; Bezak E; Todd G
    J Neurol Sci; 2023 Nov; 454():120857. PubMed ID: 37939625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson's Disease.
    Fu KA; Nathan R; Dinov ID; Li J; Toga AW
    Front Neurol; 2016; 7():174. PubMed ID: 27812347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of 3D FLAIR and Dopamine Transporter Imaging in Patients With Parkinsonism.
    Oh SW; Shin NY; Lee JJ; Lee SK; Lee PH; Lim SM; Kim JW
    AJR Am J Roentgenol; 2016 Nov; 207(5):1089-1094. PubMed ID: 27489952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding?
    Gramsch C; Reuter I; Kraff O; Quick HH; Tanislav C; Roessler F; Deuschl C; Forsting M; Schlamann M
    PLoS One; 2017; 12(10):e0185489. PubMed ID: 29016618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing Nigrosome-1 Sign Identification via Interpretable AI using True Susceptibility Weighted Imaging.
    Wang C; He N; Zhang Y; Li Y; Huang P; Liu Y; Jin Z; Cheng Z; Liu Y; Wang Y; Zhang C; Haacke EM; Chen S; Yan F; Yang G
    J Magn Reson Imaging; 2024 Nov; 60(5):1904-1915. PubMed ID: 38236577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of the appearance of Nigrosome-1 on magnetic resonance imaging in Parkinson's disease: A systematic review and meta-analysis.
    Chau MT; Todd G; Wilcox R; Agzarian M; Bezak E
    Parkinsonism Relat Disord; 2020 Sep; 78():12-20. PubMed ID: 32668370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality.
    Noh Y; Sung YH; Lee J; Kim EY
    AJNR Am J Neuroradiol; 2015 Nov; 36(11):2010-6. PubMed ID: 26294646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
    Damier P; Hirsch EC; Agid Y; Graybiel AM
    Brain; 1999 Aug; 122 ( Pt 8)():1437-48. PubMed ID: 10430830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of nigrosome-1 detection to discriminate patients with Parkinson's disease and essential tremor.
    Perez Akly MS; Stefani CV; Ciancaglini L; Bestoso JS; Funes JA; Bauso DJ; Besada CH
    Neuroradiol J; 2019 Dec; 32(6):395-400. PubMed ID: 31149866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nigrosome 1 imaging: technical considerations and clinical applications.
    Kim EY; Sung YH; Lee J
    Br J Radiol; 2019 Sep; 92(1101):20180842. PubMed ID: 31067082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.